1. Home
  2. DNTH vs SVM Comparison

DNTH vs SVM Comparison

Compare DNTH & SVM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DNTH
  • SVM
  • Stock Information
  • Founded
  • DNTH 2015
  • SVM N/A
  • Country
  • DNTH United States
  • SVM Canada
  • Employees
  • DNTH N/A
  • SVM N/A
  • Industry
  • DNTH Biotechnology: Pharmaceutical Preparations
  • SVM Precious Metals
  • Sector
  • DNTH Health Care
  • SVM Basic Materials
  • Exchange
  • DNTH Nasdaq
  • SVM Nasdaq
  • Market Cap
  • DNTH 1.5B
  • SVM 1.4B
  • IPO Year
  • DNTH N/A
  • SVM N/A
  • Fundamental
  • Price
  • DNTH $36.05
  • SVM $7.48
  • Analyst Decision
  • DNTH Strong Buy
  • SVM Strong Buy
  • Analyst Count
  • DNTH 11
  • SVM 1
  • Target Price
  • DNTH $65.22
  • SVM $6.75
  • AVG Volume (30 Days)
  • DNTH 664.6K
  • SVM 7.9M
  • Earning Date
  • DNTH 11-06-2025
  • SVM 11-06-2025
  • Dividend Yield
  • DNTH N/A
  • SVM 0.33%
  • EPS Growth
  • DNTH N/A
  • SVM N/A
  • EPS
  • DNTH N/A
  • SVM 0.25
  • Revenue
  • DNTH $4,854,000.00
  • SVM $308,064,000.00
  • Revenue This Year
  • DNTH N/A
  • SVM $10.42
  • Revenue Next Year
  • DNTH N/A
  • SVM $39.88
  • P/E Ratio
  • DNTH N/A
  • SVM $29.81
  • Revenue Growth
  • DNTH 17.87
  • SVM 35.50
  • 52 Week Low
  • DNTH $13.37
  • SVM $2.87
  • 52 Week High
  • DNTH $40.16
  • SVM $7.78
  • Technical
  • Relative Strength Index (RSI)
  • DNTH 57.06
  • SVM 69.41
  • Support Level
  • DNTH $33.34
  • SVM $6.78
  • Resistance Level
  • DNTH $36.68
  • SVM $7.50
  • Average True Range (ATR)
  • DNTH 2.11
  • SVM 0.39
  • MACD
  • DNTH -0.53
  • SVM 0.01
  • Stochastic Oscillator
  • DNTH 39.74
  • SVM 82.74

About DNTH Dianthus Therapeutics Inc.

Dianthus Therapeutics Inc is a clinical-stage biotechnology company dedicated to designing and delivering novel, monoclonal antibodies with improved selectivity and potency over existing complement therapies. The company is focused on developing next-generation complement therapeutics for patients living with severe autoimmune and inflammatory diseases. The company is comprised of an experienced team of biotech and pharma executives. The company's pipeline consists of DNTH103 a subcutaneous active C1s antibody.

About SVM Silvercorp Metals Inc.

Silvercorp Metals Inc is a mineral exploration company, engaged in the acquisition, exploration, development, and mining of mineral properties. The company's producing mines are located in China, and exploration and development projects are located in China and Ecuador. Its project portfolio comprises the El Domo copper-gold and the Condor gold project in Ecuador. In addition, it operates several silver-lead-zinc mines at the Ying Mining District in Henan Province, China, and the GC silver-lead-zinc mine in Guangdong Province, China. A majority of the company's revenue is generated through the sale of silver concentrates. Its reportable operating segments are the Ying Mining District and GC Mine in China, which derive maximum revenue, and the El Domo and Condor projects in Ecuador.

Share on Social Networks: